Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells
2016 ◽
Vol 17
(8)
◽
pp. 1235
◽
2013 ◽
2017 ◽
Vol 30
(12)
◽
pp. 2187-2196
◽
2018 ◽
2018 ◽
Vol 37
(1)
◽
2016 ◽
Vol 28
(5)
◽
pp. 506-515
◽
2014 ◽
2019 ◽
Vol 845
◽
pp. 16-23
◽